Biocon likely to seek full marketing authorisation for Covid-19 drug

Retrieved on: 2021-07-25 19:07:30

Tags for this article:

Click the tags to see associated articles and topics

Biocon likely to seek full marketing authorisation for Covid-19 drug. View article details on hiswai:

Excerpt

So far, repurposed drugs, such as Gilead's remdesivir (an antiviral) or Roche's tocilizumab (an antibody), have emergency use authorizations in ...

Article found on: www.business-standard.com